A novel theranostic nanobioconjugate: I-125/131 labeled phenylalanine conjugated boron nitride nanotubes
dc.contributor.author | Guldu, Ozge Kozgus | |
dc.contributor.author | Unak, Perihan | |
dc.contributor.author | Timur, Suna | |
dc.date.accessioned | 2019-10-27T11:10:20Z | |
dc.date.available | 2019-10-27T11:10:20Z | |
dc.date.issued | 2017 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Here we report the synthesis of boron nitride nanotubes (BNNTs) via a chemical vapor deposition method, as potential agents for boron neutron capture therapy. BNNTs were functionalized with PAMAM[G-2] dendrimer and then, conjugated with L-Phe using EDC/NHS. After that, BNNTs were radiolabeled with I-125/131, which are commonly used for both therapy and diagnosis in clinical and pre-clinical studies. BNNTs were radiolabeled with a maximum yield with I-125/131 in compared with 4-borono-L-phenyalanine which is currently used as a commercial drug. Radiolabeling parameters were optimized with thin layer radiochromatography and high performance liquid radiochromatography. BNNTs are promising nanobioconjugates as new theranostic agents. | en_US |
dc.description.sponsorship | Ege University Scientific Research FundEge University [2015 NBE 002] | en_US |
dc.description.sponsorship | The authors thank to the Ege University Scientific Research Fund for the financial support through the project number 2015 NBE 002. Associate Professor Arzu Turkler Ege and Associate Professor Mehmet Ayvacikli from Celal Bayar University are acknowledged for their valuable helps during the synthesis step of BNNTs. Dr Hasan Demiroglu from Celal Bayar University is acknowledged for his helps during FTIR measurements. | en_US |
dc.identifier.doi | 10.1007/s10967-016-5127-4 | |
dc.identifier.endpage | 1762 | en_US |
dc.identifier.issn | 0236-5731 | |
dc.identifier.issn | 1588-2780 | |
dc.identifier.issn | 0236-5731 | en_US |
dc.identifier.issn | 1588-2780 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 1751 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10967-016-5127-4 | |
dc.identifier.uri | https://hdl.handle.net/11454/32386 | |
dc.identifier.volume | 311 | en_US |
dc.identifier.wos | WOS:000398027800022 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Journal of Radioanalytical and Nuclear Chemistry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Boron nitride nanotube (BNNT) | en_US |
dc.subject | Chemical vapor deposition (CVD) | en_US |
dc.subject | Poly amido amid dendrimer (PAMAM[G2]) | en_US |
dc.subject | Radioiodination | en_US |
dc.subject | I-125 | en_US |
dc.subject | I-131 | en_US |
dc.title | A novel theranostic nanobioconjugate: I-125/131 labeled phenylalanine conjugated boron nitride nanotubes | en_US |
dc.type | Article | en_US |